Showing results (1721-1730 of 6,770) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|January 1, 1986
Clinical efficacy and cost comparison of an amiloride-hydrochlorothiazide combination versus hydrochlorothiazide and wax-matrix potassium supplement in the treatment of essential hypertensionS Vardan, J Rapacke, S Mookherjee
Clinical Therapeutics|April 7, 2020
Adverse Outcomes Associated With Inpatient Administration of Beers List Medications Following Total Knee ReplacementBlake John Anderson, Mofei Liu, Xiangqin Cui, et al.
Clinical Therapeutics|March 31, 2020
Effect of 5-μg Dose of Dexmedetomidine in Combination With Intrathecal Bupivacaine on Spinal Anesthesia: A Systematic Review and Meta-analysisShuyan Liu, Peng Zhao, Yunfeng Cui, et al.
Clinical Therapeutics|March 23, 2020
Pharmacokinetic and Pharmacodynamic Characteristics of Vancomycin and Meropenem in Critically Ill Patients Receiving Sustained Low-efficiency DialysisMaura Salaroli Oliveira, Anna Silva Machado, Elisa Teixeira Mendes, et al.
Clinical Therapeutics|October 28, 2020
Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy VolunteersZhenlei Wang, Xiaogang Chen, Aiwei Li, et al.
Clinical Therapeutics|January 1, 1987
Comparison of cefatrizine and erythromycin for pediatric ear, nose, and throat infectionsG Cremonesi, V Tarantino, M Stura, et al.
Clinical Therapeutics|January 1, 1987
Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patientsJ S Gill, N Al-Hussary, A V Zezulka, et al.
Clinical Therapeutics|January 1, 1987
A clinical and mycological assessment of tioconazole solution in the treatment of superficial dermatomycosesA del Palacio Hernanz, S Lopez Gomez, L Iglesias Diez
Clinical Therapeutics|August 1, 2021
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III StudyJong Shin Woo, Soon Jun Hong, Dong Hoon Cha, et al.
Clinical Therapeutics|July 1, 2022
Evaluation of Pharmacokinetic Interactions Between the New SGLT2 Inhibitor SHR3824 and Valsartan in Healthy Chinese VolunteersYunzhe Huang, Ran Liu, Yaqin Wang, et al.
Pageof 677